Literature DB >> 9383172

Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats.

M Nagase1, T Katafuchi, S Hirose, T Fujita.   

Abstract

OBJECTIVE: To investigate tissue distribution and localization of the natriuretic peptide receptor (NPR) subtypes' messenger RNA (mRNA) and to compare their expression between stroke-prone spontaneously hypertensive rats (SHR-SP) and Wistar-Kyoto (WKY) rats.
METHODS: Total RNA was extracted from organs of SHR-SP and WKY rats aged 13 weeks. The mRNA level was examined by RNase protection assay. The localization of the transcripts was determined by in-situ hybridization.
RESULTS: In SHR-SP aged 13 weeks, NPR-A was expressed most abundantly in the adrenal gland, lung and aorta, in that order. NPR-B was expressed highly in the uterus and ovary, and also in the lung, adrenal, and brain. NPR-C was expressed predominantly in the atrium and mesentery, less so in the lung, vein, and kidney. In the adrenal gland, NPR-A was expressed mainly in zona glomerulosa cells. In the atrium, NPR-C was expressed throughout the wall. In the mesentery, NPR-C mRNA was detected mainly in adipocytes. In the kidney, NPR-C was found predominantly in podocytes. Whereas the levels of expression of NPR subtypes in most tissues examined did not differ between SHR-SP and WKY rats, the NPR-C mRNA level was significantly greater in the kidneys of SHR-SP than it was in those of WKY rats.
CONCLUSIONS: These results indicated that each NPR subtype had a distinct tissue distribution pattern and that the expression of NPR-C in the kidneys of SHR-SP was greater than that in the kidneys of WKY rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383172     DOI: 10.1097/00004872-199715110-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  17 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 2.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

Review 3.  Guanylyl cyclase structure, function and regulation.

Authors:  Lincoln R Potter
Journal:  Cell Signal       Date:  2011-09-10       Impact factor: 4.315

Review 4.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

Review 5.  NPR-C: a component of the natriuretic peptide family with implications in human diseases.

Authors:  Speranza Rubattu; Sebastiano Sciarretta; Angelica Morriello; Camilla Calvieri; Allegra Battistoni; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2010-06-19       Impact factor: 4.599

6.  Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.

Authors:  M F Goy; P M Oliver; K E Purdy; J W Knowles; J E Fox; P J Mohler; X Qian; O Smithies; N Maeda
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

7.  Preparation and Characterization of Molecularly Imprinted Polymeric Nanoparticles for Atrial Natriuretic Peptide (ANP).

Authors:  Chunyan Wang; Mark Howell; Payal Raulji; Yvonne Davis; Subhra Mohapatra
Journal:  Adv Funct Mater       Date:  2011-09-28       Impact factor: 18.808

Review 8.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

Review 10.  Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.

Authors:  Juan Brignone; Kasper Bostlund Assersen; Mia Jensen; Boye L Jensen; Brian Kloster; Morten Jønler; Lars Lund
Journal:  Pflugers Arch       Date:  2021-04-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.